|
KIF24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.794360E-04 |
| Normal-vs-Stage3 |
7.43849426498855E-15 |
| Normal-vs-Stage4 |
3.41071615395094E-12 |
| Stage1-vs-Stage2 |
9.502300E-02 |
| Stage1-vs-Stage3 |
3.570000E-01 |
| Stage1-vs-Stage4 |
1.561760E-01 |
| Stage2-vs-Stage3 |
4.026300E-02 |
| Stage2-vs-Stage4 |
1.830120E-02 |
| Stage3-vs-Stage4 |
4.962800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.86084999999059E-05 |
| Normal-vs-Asian |
1.45370382398369E-11 |
| Caucasian-vs-AfricanAmerican |
5.693400E-01 |
| Caucasian-vs-Asian |
8.923600E-01 |
| AfricanAmerican-vs-Asian |
5.785600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.30466814708097E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
8.922200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(41-60Yrs) |
2.84705592434875E-12 |
| Normal-vs-Age(61-80Yrs) |
2.32525110277493E-12 |
| Normal-vs-Age(81-100Yrs) |
4.757000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.301800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.943600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.161200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.510000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.707200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.713200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.000500E-03 |
| Classical-VS-Follicular |
3.128800E-01 |
| Classical-VS-Other |
2.225600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.703070E-03 |
| Tall-VS-Other |
9.689400E-01 |
| Tall-VS-Normal |
4.05231403988182E-14 |
| Follicular-VS-Other |
2.069000E-01 |
| Follicular-VS-Normal |
1.16199999955491E-07 |
| Other-VS-Normal |
1.014670E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.14703859930432E-12 |
| Normal-vs-N1 |
1.0991207943789E-12 |
| N0-vs-N1 |
4.327800E-02 |
|
|
